Please assess the completion status of the following clinical trial:

Trial Title: PF-06741086 Multiple Dose Study in Severe Hemophilia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Severe hemophilia A or B (Factor VIII or Factor IX activity ≤ 1%), including patients with inhibitors to Factor VIII or Factor IX~* Episodic (on-demand) treatment regimen prior to screening~* At least 6 acute bleeding episodes during the 6-month period prior to screening~Exclusion Criteria:~* Known coronary artery, thrombotic, or ischemic disease~* Currently receiving treatment for acute bleeding episodes with APCC and cannot substitute treatment with rFVIIa

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- PF-06741086 (Cohort 1) (Type: EXPERIMENTAL): None
- PF-06741086 (Cohort 2) (Type: EXPERIMENTAL): None
- PF-06741086 (Cohort 3) (Type: EXPERIMENTAL): None
- PF-06741086 (Cohort 4) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).